Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Finasteride treats hair loss and reduces prostate cancer risk.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Intradermal dutasteride effectively and safely improves hair growth in early-stage androgenetic alopecia.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

A new method was developed to accurately measure enzyme activity related to prostate health.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride can cause recurrent mouth ulcers.